Godmanchester, United Kingdom

Peter David Tiffin

This inventor holds 1 USPTO granted patent. Top assignee: Phytopharm Plc. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter David Tiffin. Retrieved from https://idiyas.com/inventor/peter-david-tiffin-x81iiojs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter David Tiffin

Introduction

Peter David Tiffin is a notable inventor based in Godmanchester, GB. He has made significant contributions to the field of steroidal sapogenins through his innovative methods. His work has implications in various applications, particularly in the pharmaceutical industry.

Latest Patents

Peter David Tiffin holds a patent for the "Stereospecific reduction of sapogen-3-ones." This patent describes a method to stereospecifically prepare a steroidal sapogenin or a derivative by reducing a 3-keto, 5β-H steroidal sapogenin with a hindered organoborane or an organo-aluminium hydride. The invention provides a convenient route to useful steroidal sapogenins such as sarsasapogenin, episarsasapogenin, smilagenin, and epismilagenin, from readily available or easily preparable starting materials.

Career Highlights

Peter David Tiffin is associated with Phytopharm Plc, where he has been instrumental in advancing research and development in the field of plant-derived compounds. His expertise in steroidal sapogenins has positioned him as a valuable asset to the company.

Collaborations

Peter has collaborated with Philip James Gunning, working together to enhance the research and development efforts at Phytopharm Plc.

Conclusion

Peter David Tiffin's innovative work in the field of steroidal sapogenins showcases his dedication to advancing scientific knowledge and practical applications. His contributions continue to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…